Research project

The Development of anti-FcgRIIB antibodies augmenting adaptive anti-cancer immunity

Staff

Lead researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Other researchers

Dr Ali Roghanian PhD, FHEA

Associate Professor

Research interests

  • Cancer immunotherapy
  • Monoclonal antibodies
  • Cellular therapies (e.g., CAR T and iNKT cells)
Connect with Ali

Research outputs